Antibodies Market to 2027 - Global Analysis and Forecasts by Type (Monoclonal Antibodies, Polyclonal Antibodies, ADCs, Others); Technology (Western Blotting, Flow Cytometry, ELISA, Immunohistochemistry, Immunofluorescence, Immunoprecipitation, Others); Application (into Proteomics, Drug Development, Genomics); End-User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes,, CROs)
Report Code: TIPRE00005787 No. of Pages: 150 Category: Biotechnology Status: Upcoming
MARKET INTRODUCTION Get more information on this report : Get more information on this report :
Antibodies are immunoglobulins, Y-shaped proteins that are produced by the immune system to help stop intruders from harming the body. When an interloper enters the body, the immune system springs into action. Antibodies find an antigen, stick to it, and recognize for the immune system the exact type of antigen so that an antibody can destroy it. Each antibody made for one and only one antigen, and it's fitted with special receptors that will only bind to that antigen.
MARKET DYNAMICS
The Antibodies market is expected to grow significantly in the coming years, owing to the key factors such as rising volume of collaborations between various industrial and academic organizations also enhances the growth of this market and prevalence of chronic disorders. The developing regions are likely to serve more growth opportunities in coming years due to the rising incidences of infectious diseases.
MARKET SCOPE
The "Global Antibodies Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Antibodies market with detailed market segmentation by type, technology, application, end user and geography. The global Antibodies market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Antibodies market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global Antibodies market is segmented on the basis of type, technology, application and end user. On the basis of type, the market is segmented into Monoclonal Antibodies, Polyclonal Antibodies, ADCs, Others. Based on the technology the market is divided into Western Blotting, Flow Cytometry, ELISA, Immunohistochemistry, Immunofluorescence, Immunoprecipitation, Others. On the basis of application, the market is segmented into Proteomics, Drug Development, Genomics. On the basis of end user, the market is segmented into Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, CROs
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Antibodies market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Antibodies marke tby each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Antibodies market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Antibodies market in these regions.
MARKET PLAYERS
The reports cover key developments in the Antibodies marketas organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Antibodies marketare anticipated to lucrative growth opportunities in the future with the rising demand for Antibodies marketin the global market. Below mentioned is the list of few companies engaged in the bioanalytical testing services market.
The report also includes the profiles of key Antibodies marketcompanies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Merck KGaAB
- Cell Signaling Technology , Inc
- BD
- F. Hoffmann-La Roche Ltd
- Bio-Rad Laboratories Inc.
- Agilent Technologies , Inc
- Beckman Coulter, Inc.
- GenScript.
- QIAGEN
- Affinity Biologicals, Inc.
Get more information on this report :
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Antibodies Market - By Type
1.3.2 Antibodies Market - By Technology
1.3.3 Antibodies Market - By Application
1.3.4 Antibodies Market - By End-User
1.3.5 Antibodies Market - By Region
1.3.5.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ANTIBODIES MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ANTIBODIES MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. ANTIBODIES MARKET - GLOBAL MARKET ANALYSIS
6.1. ANTIBODIES - GLOBAL MARKET OVERVIEW
6.2. ANTIBODIES - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. ANTIBODIES MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. MONOCLONAL ANTIBODIES
7.3.1. Overview
7.3.2. Monoclonal Antibodies Market Forecast and Analysis
7.4. POLYCLONAL ANTIBODIES
7.4.1. Overview
7.4.2. Polyclonal Antibodies Market Forecast and Analysis
7.5. ADCS
7.5.1. Overview
7.5.2. ADCs Market Forecast and Analysis
7.6. OTHERS
7.6.1. Overview
7.6.2. Others Market Forecast and Analysis
8. ANTIBODIES MARKET - REVENUE AND FORECASTS TO 2027 - TECHNOLOGY
8.1. OVERVIEW
8.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
8.3. WESTERN BLOTTING
8.3.1. Overview
8.3.2. Western Blotting Market Forecast and Analysis
8.4. FLOW CYTOMETRY
8.4.1. Overview
8.4.2. Flow Cytometry Market Forecast and Analysis
8.5. ELISA
8.5.1. Overview
8.5.2. ELISA Market Forecast and Analysis
8.6. IMMUNOHISTOCHEMISTRY
8.6.1. Overview
8.6.2. Immunohistochemistry Market Forecast and Analysis
8.7. IMMUNOFLUORESCENCE
8.7.1. Overview
8.7.2. Immunofluorescence Market Forecast and Analysis
8.8. IMMUNOPRECIPITATION
8.8.1. Overview
8.8.2. Immunoprecipitation Market Forecast and Analysis
8.9. OTHERS
8.9.1. Overview
8.9.2. Others Market Forecast and Analysis
9. ANTIBODIES MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
9.1. OVERVIEW
9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
9.3. INTO PROTEOMICS
9.3.1. Overview
9.3.2. into Proteomics Market Forecast and Analysis
9.4. DRUG DEVELOPMENT
9.4.1. Overview
9.4.2. Drug Development Market Forecast and Analysis
9.5. GENOMICS
9.5.1. Overview
9.5.2. Genomics Market Forecast and Analysis
10. ANTIBODIES MARKET - REVENUE AND FORECASTS TO 2027 - END-USER
10.1. OVERVIEW
10.2. END-USER MARKET FORECASTS AND ANALYSIS
10.3. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
10.3.1. Overview
10.3.2. Pharmaceutical and Biotechnology Companies Market Forecast and Analysis
10.4. ACADEMIC AND RESEARCH INSTITUTES,
10.4.1. Overview
10.4.2. Academic and Research Institutes, Market Forecast and Analysis
10.5. CROS
10.5.1. Overview
10.5.2. CROs Market Forecast and Analysis
11. ANTIBODIES MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Antibodies Market Overview
11.1.2 North America Antibodies Market Forecasts and Analysis
11.1.3 North America Antibodies Market Forecasts and Analysis - By Type
11.1.4 North America Antibodies Market Forecasts and Analysis - By Technology
11.1.5 North America Antibodies Market Forecasts and Analysis - By Application
11.1.6 North America Antibodies Market Forecasts and Analysis - By End-User
11.1.7 North America Antibodies Market Forecasts and Analysis - By Countries
11.1.7.1 United States Antibodies Market
11.1.7.1.1 United States Antibodies Market by Type
11.1.7.1.2 United States Antibodies Market by Technology
11.1.7.1.3 United States Antibodies Market by Application
11.1.7.1.4 United States Antibodies Market by End-User
11.1.7.2 Canada Antibodies Market
11.1.7.2.1 Canada Antibodies Market by Type
11.1.7.2.2 Canada Antibodies Market by Technology
11.1.7.2.3 Canada Antibodies Market by Application
11.1.7.2.4 Canada Antibodies Market by End-User
11.1.7.3 Mexico Antibodies Market
11.1.7.3.1 Mexico Antibodies Market by Type
11.1.7.3.2 Mexico Antibodies Market by Technology
11.1.7.3.3 Mexico Antibodies Market by Application
11.1.7.3.4 Mexico Antibodies Market by End-User
11.2. EUROPE
11.2.1 Europe Antibodies Market Overview
11.2.2 Europe Antibodies Market Forecasts and Analysis
11.2.3 Europe Antibodies Market Forecasts and Analysis - By Type
11.2.4 Europe Antibodies Market Forecasts and Analysis - By Technology
11.2.5 Europe Antibodies Market Forecasts and Analysis - By Application
11.2.6 Europe Antibodies Market Forecasts and Analysis - By End-User
11.2.7 Europe Antibodies Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Antibodies Market
11.2.7.1.1 Germany Antibodies Market by Type
11.2.7.1.2 Germany Antibodies Market by Technology
11.2.7.1.3 Germany Antibodies Market by Application
11.2.7.1.4 Germany Antibodies Market by End-User
11.2.7.2 France Antibodies Market
11.2.7.2.1 France Antibodies Market by Type
11.2.7.2.2 France Antibodies Market by Technology
11.2.7.2.3 France Antibodies Market by Application
11.2.7.2.4 France Antibodies Market by End-User
11.2.7.3 Italy Antibodies Market
11.2.7.3.1 Italy Antibodies Market by Type
11.2.7.3.2 Italy Antibodies Market by Technology
11.2.7.3.3 Italy Antibodies Market by Application
11.2.7.3.4 Italy Antibodies Market by End-User
11.2.7.4 Spain Antibodies Market
11.2.7.4.1 Spain Antibodies Market by Type
11.2.7.4.2 Spain Antibodies Market by Technology
11.2.7.4.3 Spain Antibodies Market by Application
11.2.7.4.4 Spain Antibodies Market by End-User
11.2.7.5 United Kingdom Antibodies Market
11.2.7.5.1 United Kingdom Antibodies Market by Type
11.2.7.5.2 United Kingdom Antibodies Market by Technology
11.2.7.5.3 United Kingdom Antibodies Market by Application
11.2.7.5.4 United Kingdom Antibodies Market by End-User
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Antibodies Market Overview
11.3.2 Asia-Pacific Antibodies Market Forecasts and Analysis
11.3.3 Asia-Pacific Antibodies Market Forecasts and Analysis - By Type
11.3.4 Asia-Pacific Antibodies Market Forecasts and Analysis - By Technology
11.3.5 Asia-Pacific Antibodies Market Forecasts and Analysis - By Application
11.3.6 Asia-Pacific Antibodies Market Forecasts and Analysis - By End-User
11.3.7 Asia-Pacific Antibodies Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Antibodies Market
11.3.7.1.1 Australia Antibodies Market by Type
11.3.7.1.2 Australia Antibodies Market by Technology
11.3.7.1.3 Australia Antibodies Market by Application
11.3.7.1.4 Australia Antibodies Market by End-User
11.3.7.2 China Antibodies Market
11.3.7.2.1 China Antibodies Market by Type
11.3.7.2.2 China Antibodies Market by Technology
11.3.7.2.3 China Antibodies Market by Application
11.3.7.2.4 China Antibodies Market by End-User
11.3.7.3 India Antibodies Market
11.3.7.3.1 India Antibodies Market by Type
11.3.7.3.2 India Antibodies Market by Technology
11.3.7.3.3 India Antibodies Market by Application
11.3.7.3.4 India Antibodies Market by End-User
11.3.7.4 Japan Antibodies Market
11.3.7.4.1 Japan Antibodies Market by Type
11.3.7.4.2 Japan Antibodies Market by Technology
11.3.7.4.3 Japan Antibodies Market by Application
11.3.7.4.4 Japan Antibodies Market by End-User
11.3.7.5 South Korea Antibodies Market
11.3.7.5.1 South Korea Antibodies Market by Type
11.3.7.5.2 South Korea Antibodies Market by Technology
11.3.7.5.3 South Korea Antibodies Market by Application
11.3.7.5.4 South Korea Antibodies Market by End-User
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Antibodies Market Overview
11.4.2 Middle East and Africa Antibodies Market Forecasts and Analysis
11.4.3 Middle East and Africa Antibodies Market Forecasts and Analysis - By Type
11.4.4 Middle East and Africa Antibodies Market Forecasts and Analysis - By Technology
11.4.5 Middle East and Africa Antibodies Market Forecasts and Analysis - By Application
11.4.6 Middle East and Africa Antibodies Market Forecasts and Analysis - By End-User
11.4.7 Middle East and Africa Antibodies Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Antibodies Market
11.4.7.1.1 South Africa Antibodies Market by Type
11.4.7.1.2 South Africa Antibodies Market by Technology
11.4.7.1.3 South Africa Antibodies Market by Application
11.4.7.1.4 South Africa Antibodies Market by End-User
11.4.7.2 Saudi Arabia Antibodies Market
11.4.7.2.1 Saudi Arabia Antibodies Market by Type
11.4.7.2.2 Saudi Arabia Antibodies Market by Technology
11.4.7.2.3 Saudi Arabia Antibodies Market by Application
11.4.7.2.4 Saudi Arabia Antibodies Market by End-User
11.4.7.3 U.A.E Antibodies Market
11.4.7.3.1 U.A.E Antibodies Market by Type
11.4.7.3.2 U.A.E Antibodies Market by Technology
11.4.7.3.3 U.A.E Antibodies Market by Application
11.4.7.3.4 U.A.E Antibodies Market by End-User
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Antibodies Market Overview
11.5.2 South and Central America Antibodies Market Forecasts and Analysis
11.5.3 South and Central America Antibodies Market Forecasts and Analysis - By Type
11.5.4 South and Central America Antibodies Market Forecasts and Analysis - By Technology
11.5.5 South and Central America Antibodies Market Forecasts and Analysis - By Application
11.5.6 South and Central America Antibodies Market Forecasts and Analysis - By End-User
11.5.7 South and Central America Antibodies Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Antibodies Market
11.5.7.1.1 Brazil Antibodies Market by Type
11.5.7.1.2 Brazil Antibodies Market by Technology
11.5.7.1.3 Brazil Antibodies Market by Application
11.5.7.1.4 Brazil Antibodies Market by End-User
11.5.7.2 Argentina Antibodies Market
11.5.7.2.1 Argentina Antibodies Market by Type
11.5.7.2.2 Argentina Antibodies Market by Technology
11.5.7.2.3 Argentina Antibodies Market by Application
11.5.7.2.4 Argentina Antibodies Market by End-User
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. ANTIBODIES MARKET, KEY COMPANY PROFILES
13.1. MERCK KGAAB
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. CELL SIGNALING TECHNOLOGY , INC
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. BD
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. F. HOFFMANN-LA ROCHE LTD
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. BIO-RAD LABORATORIES INC.
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. AGILENT TECHNOLOGIES , INC
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. BECKMAN COULTER, INC.
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. GENSCRIPT.
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. QIAGEN
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. AFFINITY BIOLOGICALS, INC
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies
1. Merck KGaAB
2. Cell Signaling Technology , Inc
3. BD
4. F. Hoffmann-La Roche Ltd
5. Bio-Rad Laboratories Inc.
6. Agilent Technologies , Inc
7. Beckman Coulter, Inc.
8. GenScript.
9. QIAGEN
10. Affinity Biologicals, Inc.